期刊文献+

不同心绞痛患者血清脑钠肽的临床意义 被引量:3

The Clinical Value of the Serum BNP in the Angina Pectoris Patients
下载PDF
导出
摘要 目的:探讨心绞痛患者血清脑钠肽(BNP)水平在评估心功能以及冠状动脉病变程度方面的临床价值。方法:经选择性冠状动脉造影(CAG)证实为心绞痛的患者68例,其中稳定型心绞痛(SA)患者32例,不稳定型心绞痛(UA)患者36例,根据NYHA标准分为心功能Ⅰ~Ⅳ级,采用荧光免疫法定量测定患者血清BNP水平、彩色超声心动图测定左室射血分数(LVEF),分析BNP水平与不同病情的关系。结果:BNP水平随着病情加重而逐渐升高,且与心功能的级别、冠脉的病变呈正相关(分别为r=0.82,P<0.05;r=0.68,P<0.05),与左室射血分数呈负相关(r=-0.53,P<0.05)。结论:BNP是检测心功能衰竭和冠脉病变的重要指标,对临床病情的评估具有重要价值。 Objective: To investigate the clinical value of brain natriuretic peptide (BNP) in the evaluation of heart function and degree of the coronary artery disease in the angina pectoris patients. Methods: 68 patients of angina pectoris which was diagnosed by selected coronary angiography (CAC) were selected, including 32 stable angina patients and 36 unstable angina patients, whose heart function were classified to Ⅰ~Ⅳ based on NYHA. The difference of plasma BNP level was measured by fluomimmunoassay, and left ventricular ejection fraction (LVEF) was detected by color Doppler and the relationship between the BNP level and the different coronary artery lesion was analyzed. Results: The level of plasmaBNP elevated in these patients with the increase of the degree of lesion. It was positively correlated with the degree of coronary lesion and heart function (r = 0.82,P 〈 0.05;r = 0.68,P 〈 0.05 respectively), and negatively correlated with LVEF (r = -0.53,P 〈 0.05). Conclusion: The level of plasma BNP is a useful marker for diagnosis of heart failure and coronary artery disease, and have great value for the evaluation of these diseases.
出处 《天津医药》 CAS 北大核心 2006年第1期13-14,共2页 Tianjin Medical Journal
关键词 冠状动脉疾病 利钠肽 心力衰竭 充血性 荧光免疫测定 coronary disease natriuretic peptide,brain heart failure, congestive fluoroimmunoassay
  • 相关文献

参考文献6

  • 1The Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature and Criteria of Ischemic Heart Disease (Special Report).Circulation,1979,59:607-614.
  • 2Hunt SA,Baker DW,Chin MH,et al.ACC/AHH Guidelines for the evaluation and management of chronic heart failure.Circulation,2001,104:2996-3007.
  • 3Goto T,Takase H,Toriyama T,et al.Circulating concentrations of cardiae proteins indicate the severity of congestive heart failure.Heart,2003,89:1303-1307.
  • 4Yamaguchi H,Yoshida J,Yamamoto K,et al.Elevation of plasma brain natriuretic peptide is a hallmark of diastalic heart failure independent of ventricular hypertrophy.J Am Coll Cardiol,2004,43:55-60.
  • 5Mccullough PA,Omland T,Maisel AS.B-Type natriuretic peptides:a diagnostic breakthrough for clinicians.Rev Cardiovasc Med,2003,4:72-80.
  • 6林雪,朱文玲,方理刚.脑钠肽在心力衰竭和心肌梗死中的临床意义[J].中华心血管病杂志,2004,32(5):469-471. 被引量:47

二级参考文献23

  • 1Sudon T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature,1988,322:78-81.
  • 2Venugopal J. Cardiac natriuretic peptide-hope or hype? J Clinical Pharmacy Theraperutics, 2001,26:15-31.
  • 3Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormaones in humans. Horm Metab Res,1999,31:487-498.
  • 4Mair J, Friedl W, Thomas S, et al. Natriuretic peptides in assessment of left-ventricular dysfunction.Scand J Clin Invest, 1999,(Supple 230):132-142.
  • 5Sagnella GA. Mearement and significance of circulating natriuretic peptides in cardiovascular disease. Clinical Science,1998,95:519-529.
  • 6Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand,2001,171:395-403.
  • 7Goto T, Takase H, Toriyama T, et al.Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart, 2003,89:1303-1307.
  • 8Smith H, Picking R M,Struthers A, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ, 2000, 320:1.
  • 9Ninuma H, Nakamura M, Hiramori K. Plasma B-type natriuretic peptide measurement in multiphasic health screening program. Cardiology,1998,90:89-94.
  • 10Tang WH, Girod JP, Lee MJ, et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation, 2003,108: 2964-2966.

共引文献46

同被引文献19

  • 1艾民,乔玉花,李凌,董建增,付九红,付凤云.207例前壁心肌梗死患者冠状动脉造影分析[J].实用诊断与治疗杂志,2006,20(1):19-20. 被引量:9
  • 2王琳,熊为国,郭晓宁,陈新.脑利钠肽的生理特性及其重组脑利钠肽在急性心力衰竭治疗中的应用[J].中华心律失常学杂志,2006,10(1):77-78. 被引量:16
  • 3赵季红,陈炳伟,姜铁民,李玉明,刘军翔.急性冠状动脉综合征患者血清脑钠肽浓度的变化及临床意义[J].临床心血管病杂志,2007,23(3):182-183. 被引量:18
  • 4Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased BNP expression associated with myocardial ischemia[J]. FASEB J, 2003, 7:1 105-107.
  • 5Marumoto K,Hamada M,Hiwada K.Increased secretion of atrial and brain natriuretic pepetides during acute myocardial ischaemia induced by dynamic exercise in-pateints with angina pectoris[J]. Clin Sci, 1995, 88: 551-556.
  • 6Dawson A, Jeyaseelan S, Morris AD, Struthers AD. B-type natriuretic peptide as an altemative way of assessing total cardiovascular risk in patients with diabetes mellitus[J]. Am J Cardiol, 2006, 15, 97 (4) : 592.
  • 7Igarashi M, Jimbu Y, Hirata A, Tominaga M. Characterization of plasma brain natriuretic peptide level in patients with type 2 diabetes [J]. Endocr J, 2005, 52 (3) : 353-356.
  • 8Casco VH, Veinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries[J]. Histochem Cytochem, 2002, 50 (6): 799-809.
  • 9Struthers AD,Davies J.B-type natriuretic peptide:a simple new test to identify coronary artery disease [ J]. 2005, 98(10) : 765-769.
  • 10陆晓骅,鲍思蔚,翟晓波.罗格列酮对冠心病合并2型糖尿病患者IL-6、TNFα的影响[J].实用诊断与治疗杂志,2007,21(12):891-892. 被引量:8

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部